Zelnorm news from FiercePharma
News
Novartis restricts Zelnorm to emergencies
Goodbye cruel world. Novartis is pulling the irritable bowel med Zelnorm off the market almost completely, saying it will supply the drug only for emergency use. And even in emergencies, Zelnorm will Read more...
Novartis CEO's pay drops with profits
Novartis had a tough year in 2007: Its vaunted new diabetes drug Galvus got the stiff-arm treatment from Read more...
7. Zelnorm - Top 10 Warnings and Recalls
Drug: Zelnorm 2006 sales: $561 million Manufacturer: Novartis Safety concern: Recall; heart risks Related Articles: > FDA allows limited Zelnorm use. Read more...
Get more Zelnorm coverage at:
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends